Cancer Clinical Investigation

Search results

• The Symptoms of Metastatic Breast Cancer You Shouldn’t Ignore, According to a Cancer Doctor access_time2:49

  Tiersten, A.

  11/05/23

  1 item of Media coverage

  Press/Media

• Pancreatic cancer vaccine shows promise in small trial

  Bhardwaj, N.

  10/05/23

  2 items of Media coverage

  Press/Media

• Pancreatic Cancer Vaccine Shows Promise in Small Trial

  Bhardwaj, N.

  10/05/23

  5 items of Media coverage

  Press/Media

• VIDEO: Neoadjuvant, adjuvant studies show promise in preventing HCC recurrence

  Marron, T.

  10/05/23

  1 item of Media coverage

  Press/Media

• Pioneering mRNA Cancer Vaccine Averts Return of Deadliest Cancers in Half of Recipients

  Bhardwaj, N.

  10/05/23

  1 item of Media coverage

  Press/Media

• VIDEO: Following up IMbrave050 study will be important in hepatocellular carcinoma

  Marron, T.

  9/05/23

  1 item of Media coverage

  Press/Media

• VIDEO: Circulating tumor DNA levels could help predict hepatocellular carcinoma recurrence

  Marron, T.

  9/05/23

  1 item of Media coverage

  Press/Media

• Increased Besremi Dose to Be Studied for Polycythemia Vera Treatment

  Mascarenhas, J.

  9/05/23

  1 item of Media coverage

  Press/Media

• Studies in the Area of Cancer Reported from Memorial Sloan-Kettering Cancer Center (Rapid cancer cell perineural invasion utilizes amoeboid migration)

  Bakst, R. & Powers, A.

  8/05/23

  1 item of Media coverage

  Press/Media

• Dr Galsky on the Need for Novel Drug Classes and Non–Cross-Resistant Options in mRCC

  Galsky, M.

  8/05/23

  1 item of Media coverage

  Press/Media

• MorphoSys AG (MOR) Q1 2023 Earnings Call Transcript

  Mascarenhas, J.

  6/05/23

  1 item of Media coverage

  Press/Media

• Immunotherapy After Surgery Shows Long-Term Benefits for High-Risk Bladder Cancer

  Galsky, M.

  5/05/23

  1 item of Media coverage

  Press/Media

• -Lytix Biopharma to present at the 'Frontiers in Cancer Immunotherapy 2023', invited by New York Academy of Sciences

  Bhardwaj, N.

  4/05/23

  2 items of Media coverage

  Press/Media

• PharmaEssentia Initiates Phase 3b Trial of Ropeginterferon alfa-2b-njft Investigatng New Dosing Regimen for Patients With Polycythemia Vera (PV)

  Mascarenhas, J.

  3/05/23

  1 item of Media coverage

  Press/Media

• Lytix Biopharma To Present At The 'Frontiers In Cancer Immunotherapy 2023', Invited By New York Academy Of Sciences

  Bhardwaj, N.

  3/05/23

  1 item of Media coverage

  Press/Media

• Lytix Biopharma to present at the 'Frontiers in Cancer Immunotherapy 2023', invited by New York Academy of Sciences

  Bhardwaj, N.

  3/05/23

  188 items of Media coverage

  Press/Media

• Lytix Biopharma to present at the 'Frontiers in Cancer Immunotherapy 2023', invited by New York Academy of Sciences

  Bhardwaj, N.

  3/05/23

  1 item of Media coverage

  Press/Media

• PharmaEssentia Initiates Phase 3b Trial of Ropeginterferon alfa-2b-njft Investigatng New Dosing Regimen for Patients With Polycythemia Vera (PV); Single-arm trial will evaluate an accelerated dosing schedule

  Mascarenhas, J.

  2/05/23 → 3/05/23

  12 items of Media coverage

  Press/Media

• PharmaEssentia Initiates Phase 3b Trial of ropeginterferon alfa-2b-njft Investigating New Dosing Regimen for Patients with Polycythemia Vera (PV)

  Mascarenhas, J.

  3/05/23

  1 item of Media coverage

  Press/Media

• Zhengzhou University of Aeronautics Reports Findings in Technology (Electronically Controlled Infrared Radiation of Graphite Thin Films With Crumpled Surfaces)

  Wang, P.

  3/05/23

  1 item of Media coverage

  Press/Media

• Key Trial Updates Confirm and Clarify Treatment Approaches Across Genitourinary Cancers

  Galsky, M.

  2/05/23

  1 item of Media coverage

  Press/Media

• Lymphoma Research Foundation Awards More Than $5.4 Million in Lymphoma Research Grants

  Brody, J.

  2/05/23

  77 items of Media coverage

  Press/Media

• Lymphoma Research Foundation Awards More Than $5.4 Million in Lymphoma Research Grants.

  Brody, J.

  2/05/23

  1 item of Media coverage

  Press/Media

• Melanoma Research Alliance Announces $6.3 Million In Grants To Advance Melanoma Prevention, Detection & Treatment

  Poulikakos, P. & Chowell, D.

  1/05/23

  1 item of Media coverage

  Press/Media

• Melanoma Research Alliance Announces $6.3 Million In Grants To Advance Melanoma Prevention, Detection & Treatment

  Poulikakos, P. & Chowell, D.

  1/05/23

  234 items of Media coverage

  Press/Media